Lung Cancer Research Explained

We’re finding answers about every stage of lung cancer

One overarching question guides our lung cancer research: If we don’t do this research, will it be done?

Our goal is to answer important questions about improving the lives of lung cancer patients—questions others may not be asking. The answers we find expand treatment options, increase survival, and enhance patients’ quality of life. 

Guided by that overarching question, our researchers can answer critical questions more quickly, explore drug combinations that have fewer side effects, see whether immunotherapy might benefit patients with early-stage disease, and evaluate biomarkers that tell us if a person’s cancer has been eradicated and treatment can end.

The progress we make gives hope to lung cancer patients in Indiana and around the world.

#ResearchCuresCancer.

It's time to end lung cancer—now

Together, we’re going to turn the tide against this disease.

Prevention Screening Advocacy

NEW! Rapid Access Clinic

At IU Health’s new Rapid Access Clinic, you’ll receive prompt access to the specialized care you need to achieve the best possible outcome.

If you’re told you may have cancer, a certified physician assistant will guide you through an expedited diagnostic process that gets you into treatment faster and back to life more quickly.

Learn More

What does a lung cancer patient look like?

When people find out Alesha Arnold has lung cancer, their typical response is, “But you didn’t smoke, did you?”

Alesha Arnold—a registered nurse who never smoked—was shocked by her diagnosis in 2019 at age 44. After testing, she learned she inherited a genetic vulnerability that unknowingly increased her risk for lung cancer.

Alesha Arnold, registered nurse and lung cancer patient, with her family

Now she’s fighting the stigma that smoking is the only cause of lung cancer. She’s adding her voice as an advocate through End Lung Cancer Now, our initiative to dispel myths, increase enrollment in clinical trials, and eliminate barriers for underrepresented populations.

Alesha's JourneyEnd Lung Cancer Now 

 

Lung cancer doesn’t discriminate. If you have lungs, you can get lung cancer.

Alesha Arnold, RN — Clinical research nurse and lung cancer patient

Clinical trials

We can cure cancer, but we can’t do it alone—find out if you or a loved one might qualify for one of our research studies.

Rebuilding health: Victor’s story

Victor Rigdon can fix just about anything in his job as a carpenter at Indiana State Fairgrounds & Event Center. But in 2015, Rigdon found something he couldn’t fix—Stage IV non-small cell lung cancer.

Victor Rigdon a carpenter at the Indiana State Fairgrounds, can fix just about anything

The standard treatment options were limited, so Victor volunteered to try something new. A combination of chemotherapy and immunotherapy drugs shrunk his tumor significantly, with no side effects.

Victor’s still working and his disease remains in check. His treatment amounts to getting stuck with a needle every three weeks and taking a half-day off from work. Now he has other, more pressing concerns–like the itinerary for his next travel adventure.

Read Victor’s Story What is Immunotherapy?

Screening for lung cancer with a low-dose CT scan significantly reduces mortality, but less than 10 percent of eligible people participate.

Making progress and building hope

Listen to what End Lung Cancer Now founder Dr. Nasser Hanna has to say about the goals and importance of what we do.

Fewer than 5 percent of Hoosiers with cancer participate in a clinical trial, which means 95 percent of people with advanced cancers are not getting the better therapies of tomorrow.

Nasser Hanna, MD — Tom and Julie Wood Family Foundation Chair in Lung Cancer Clinical Research

Simon Says Expert Series

Our monthly video series brings together cancer center researchers and physicians, patient advocates, and others to talk about various cancer-related topics.

We’ve covered “chemobrain,” fear of cancer recurrence, health disparities, exercise and physical therapy, the emerging field of supportive oncology, and more.

Coming Soon Recorded Sessions

#ResearchCuresCancer

Support Our Research